WiLing Wednesdays live webinar educational series - recording links are available here:
SERIES 9 – MANTLE CELL LYMPHOMA (MCL) - May 2023
Session 1 - MCL Treatment
Session 2 - MCL Prognostication
Session 3 - Pathogenesis & Biology
SERIES 8 – CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) - February/March 2023
Session 1 - CLL frontline treatment/new drugs/global access
Session 2 - Tough CLL
Session 3 - Career Development
Session 4 - Optimal Investigation of CLL - molecular studies, risk stratification & MRD
SERIES 7 - LYMPHOMA & THE BRAIN - September/October 2022
Session 1 - PCSNL - Diagnosis and Treatment
Session 2 - PSNSL - Elderly and side effects
SESSION 3 - SCNSL and CAR-T
SESSION 4 - Debate on CNS Prophylaxis
SESSION 5 - Other brain lymphomas & imaging
SERIES 6 - CELLULAR THERAPY - April/May 2022
SESSION 1 - Defining Cellular Therapies
SESSION 2 - CAR-T Cells in different clinical settings - Treatment of DLBCL/Treatment of FL, MCL, CLL
SESSION 3 - Moving forward in CAR-T Cell - Mechanisms of Resistance/Modified CAR-T Strategies – Allo CAR-T, Dual CAR-T
SESSION 4 - CAR-T Strategies vs. BiTes
SESSION 5 - Global discussion on access, application, real-life experiences & challenges
SERIES 5 - CAREER DEVELOPMENT - Part 1 - March/April 2022
Session 1 - APPs
Session 2 - Legendary WiL
SERIES 4 – INDOLENT LYMPHOMA - October/November 3, 2021
Session 1 - Living with Follicular Lymphoma/Follicular Lymphoma pathogenesis and clonal evolution, transformed FL
Session 2 - Risk stratification in Follicular Lymphoma/Utility of PET in Follicular Lymphoma
Session 3 - Advances for treatment for Follicular Lymphoma/Treatment paradigms for relapsed and refractory Follicular Lymphoma
Session 4A - Career Development with Change Champions and their Mentees
Session 4B - Career Development with Change Champions and their Mentees
Session 5 - Treatment options in Marginal Zone Lymphoma/Waldenstrom’s Macroglobulinemia
SERIES 3 - T-CELL LYMPHOMA - April/May 2021
Session 1 - Update on T-cell : Lymphoma HemPath review/Primary therapy of common peripheral T-cell lymphoma
Session 2 - HemPath review of T-cell lymphomas common in Asia/Frontline & Salvage therapies for T-cell lymphomas common in Asia
Session 3 - Treatment & outcome for relapsed T-cell lymphomas/Use of autologous & allogenuc transplant for T-cell lymphomas
Session 4 - Newer therapies & Clinical trials for T-cell lymphomas/Case studies of T-cell lymphomas
Session 5 - Career Development
SERIES 2 - HODGKIN LYMPHOMA - January/February 2021
https://www.youtube.com/@womeninlymphoma
SERIES 1 - DLBCL - September 2020
Recordings are not available unfortunately.